AIIMS-led GRASSROOT trial proved India-made Supernova stent safe and effective for severe strokes, earning CDSCO approval. Lower-cost device could expand access to lifesaving thrombectomy nationwide.

Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Discover why Penumbra (PEN) is poised for growth in thrombectomy markets. Explore key studies, upcoming launches, and ...

The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Vesalio, a leader in thrombectomy solutions, today announced FDA 510(k) clearance and the upcoming U.S. commercial launch of ...

The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. Rapid Medical, a ...

Rapid Medical completes DISTALS enrollment for TIGERTRIEVER 13 for DMVO stroke, backed by interim safety data and demand for distal-specific devices.

Rapid Medicaltm, a leading developer of active endovascular devices, announces the completion of patient enrollment in the DISTALS Trial, a multicenter randomized study assessing the TIGERTRIEVER 13tm ...

The Supernova Stent is a new and advanced brain treatment device -- has been demonstrated to be safe and effective for stroke patients, said experts at AIIMS ...

AIIMS Delhi's GRASSROOT trial marks India's first brain stent success for stroke care, with Supernova restoring blood flow in ...